glp-1 and thc Modern Medicine: How Medical Marijuana Fits into the "GLP-1" Weight Loss Era GLP-1 agonists reduce substance use

Somatostatin, secreted from pancreatic -cells, acts as an inhibitory paracrine to suppress glucagon release from pancreatic -cells, and specific blockade of SSRT2 eliminates the inhibitory effect of GLP-1 on glucagon secretion

Nausea and appetite changes Nausea is the single most reported side effect across all GLP-1 agonist peptides, and retatrutide is no exception

Semaglutide is already established in injectable forms for weight management and diabetes, and this marks its first approval in a high-dose oral format specifically for obesity management

GLP-1 medications such as semaglutide and tirzepatide have transformed obesity and metabolic disease treatment

The FDA has approved semaglutide for weight management in non-diabetic adults with obesity through the brand name Wegovy

For example, we have a protein on all our cell membranes called the sodium-potassium pump, and as the name implies, it requires both electrolytes (sodium and potassium) in specific quantities to facilitate nerve signaling and muscle contraction.So instead of focusing on how GLP-1 RAs might affect each individual electrolyte, a more helpful approach is to understand what complications might arise from GLP-1 usage and when they warrant attention."It depends on how an individual responds to their GLP-1 RA," Dr